Parkinson's Disease Genetics Database

Northwell Health1 site in 1 country16 target enrollmentFebruary 2008

ConditionsParkinson's Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Parkinson's Disease
Sponsor: Northwell Health
Enrollment: 16
Locations: 1
Primary Endpoint: the current protocol is for establishment of the registry only and not for particular analyses of its contents
Status: Terminated
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The goal of the study is to develop and organize an effort to identify genes that determine an individual's risk for developing Parkinson's disease (PD).

To ascertain, study and establish a repository of DNA samples that will allow for the identification of known and yet-to-be-identified genetic markers associated with the development of PD.
To create a database with clinical, genetic (HLA, genome screen) and medical history information that will facilitate the search for PD susceptibility genes.
To provide a centralized DNA repository to allow for targeted studies of genetic factors contributing to the onset, heterogeneity and progression of PD.
To evaluate opportunities to extend the results of research to develop methods of risk prediction, prevention and therapy for PD.

Registry

clinicaltrials.gov

Start Date

February 2008

End Date

February 2013

Last Updated

10 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Northwell Health

Responsible Party

Principal Investigator

Michael Pourfar

Principal Investigator

Northwell Health

Eligibility Criteria

Inclusion Criteria

•Subjects must have a diagnosis of Parkinson's Disease as determined by standard neurological criteria.
•Patients ≥18 years of age who are able to provide informed consent
•Patients ≥ 18 who are decisionally impaired for whom informed consent can be obtained by a legally authorized representative.